84.39
0.95 (1.14%)
| 前收盘价格 | 83.44 |
| 收盘价格 | 83.43 |
| 成交量 | 294,482 |
| 平均成交量 (3个月) | 365,027 |
| 市值 | 4,170,106,624 |
| 市盈率 (P/E TTM) | 19.67 |
| 预期市盈率 (P/E Forward) | 17.54 |
| 价格/销量 (P/S) | 3.68 |
| 股市价格/股市净资产 (P/B) | 2.25 |
| 52周波幅 | |
| 利润日期 | 6 Aug 2025 - 11 Aug 2025 |
| 营业毛利率 | 18.86% |
| 营业利益率 (TTM) | 34.03% |
| 稀释每股收益 (EPS TTM) | 4.29 |
| 季度收入增长率 (YOY) | 7.10% |
| 季度盈利增长率 (YOY) | 1.40% |
| 总债务/股东权益 (D/E MRQ) | 56.91% |
| 流动比率 (MRQ) | 4.20 |
| 营业现金流 (OCF TTM) | 251.52 M |
| 杠杆自由现金流 (LFCF TTM) | 188.69 M |
| 资产报酬率 (ROA TTM) | 6.50% |
| 股东权益报酬率 (ROE TTM) | 12.30% |
市场趋势
| 短期 | 中期 | ||
| 行业 | Drug Manufacturers - Specialty & Generic (US) | 看跌 | 混合的 |
| Drug Manufacturers - Specialty & Generic (全球的) | 看跌 | 混合的 | |
| 股票 | Prestige Consumer Healthcare In | 混合的 | 看涨 |
AIStockmoo 评分
| 分析师共识 | -2.0 |
| 内部交易活动 | NA |
| 价格波动 | 2.0 |
| 技术平均移动指标 | 1.0 |
| 技术振荡指标 | -0.5 |
| 平均 | 0.13 |
|
Prestige Consumer Healthcare is one of the largest pure-play over-the-counter healthcare providers. It has a diverse portfolio composed of leading brands in niche consumer health categories. Prestige’s key brands include Clear Eyes (redness relief), Dramamine (motion sickness relief), Monistat (vaginal anti-fungal), and Summer’s Eve (feminine hygiene), and many of its brands enjoy category leadership and recommendations from medical professionals. The firm mainly plays in North America where it generates roughly 85% of its total revenue, and the remaining sales come from Australia, New Zealand, and certain Asian markets. |
|
| 部门 | Healthcare |
| 行业 | Drug Manufacturers - Specialty & Generic |
| 投资方式 | Small Core |
| 内部持股比例 | 1.43% |
| 机构持股比例 | 107.23% |
该时间范围内无数据。
该时间范围内无数据。
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合